Moderna chief executive officer talks Q1 earnings, Brazil COVID vaccine, and cancer treatment markets
Shares of pharmaceutical enterprise Moderna (MRNA) are on the rise despite first quarter losses. Moderna chief executive officer Stéphane Bancel tells Yahoo money management Senior Reporter Anjalee Khemlani that the enterprise is busy developing updated coronavirus vaccines for the 2024-2025 season and recently announced an expansion into the Brazilian industry. As the coronavirus pandemic has … Read more